Browse Pharmaceutical industry topic

Forecasts and trends subtopic

Articles 1-100 out of 100 article(s) Title Author Type Date Words Zacks Releases New Stock Picks from the +21.7% Momentum Strategy: AstraZeneca, Gerdau Ameristeel Corp, ReneSola Ltd, Reinsurance Group of America and AeroCentury Corp. Oct 9, 2008 921 A Company and Industry Analysis of the European Pharmaceutical Sectors Providing the Latest Data on the Current Environment & Market Trends. Industry overview Oct 7, 2008 614 Examine This Global Vaccine Market Forecast to 2012 as the Market is Expected to Emerge as the Fastest Growing Therapy Area in the Next 5 Years. Industry overview Oct 7, 2008 534 Fitch Affirms Eli Lilly & Co.'s IDR at 'AA'; Outlook Stable. Oct 1, 2008 537 Thomas Pharmaceuticals Announces Corporate Reorganization and Business Outlook. Sep 23, 2008 627 Bulgaria Pharmaceuticals and Healthcare Report Q3 2008 Provides Independent Forecasts on Bulgaria's Pharmaceuticals and Healthcare Industry. Sep 22, 2008 574 This Report Reveals the Findings of the Pharmaceutical Raw Materials Manufacturing in China. Sep 3, 2008 302 Research and Markets: An Analysis of Eli Lilly, One of the Top 10 World's Leading Pharmaceutical Companies: Including a Financial Analysis, and Overview of Major Trends. Aug 26, 2008 403 Fueling the Drug Discovery Engine: Biotech Investment and Business Trends. Aug 21, 2008 605 An Essential Analysis and Forecast on Key Pricing and Reimbursement Trends for CNS Drugs. Aug 21, 2008 603 Contract Manufacturing Strategies: Market Developments, Technology Transfer and Key Success Factors. Aug 6, 2008 941 Fitch Downgrades Abbott Laboratories' IDR to 'A+'; Outlook to Stable. Aug 4, 2008 551 Allergan Reports Second Quarter 2008 Operating Results. Financial report Jul 30, 2008 2161 Pfizer Reports Second-Quarter 2008 Results. Financial report Jul 23, 2008 4618 Assess the Impact of Patent Expiry for Lipitor on the Commercial Outlook of Pfizer Over 2006-12 with the 'Pfizer Inc: Pharmavitae Profile'. Jul 10, 2008 545 What Factors are Leading to an Increase in the Commercial Value of New Products? Jun 18, 2008 617 Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook. May 16, 2008 831 Crystallize Your Business Decisions with Drug Approval Trends at the FDA and EMEA Report. May 13, 2008 666 Allergan Reports First Quarter 2008 Operating Results. Financial report May 7, 2008 2205 Economic impact: industry raises salary averages: housing prices, retail sales among sectors that get boost from Amgen, other firms. Kareem, Nadra Apr 28, 2008 1045 Research and Markets: Oman's Drug Market Is Expected to Grow Strongly Over the Forecast Period (2008-2012) to Reach a Value of US$181.7mn by 2012. Apr 23, 2008 442 The Outlook for the Cardiovascular Disorders Market Remains Robust According to New Report. Apr 7, 2008 854 Fitch Initiates an 'A' IDR on Amgen; Outlook Stable. Apr 3, 2008 644 Research and Markets: Bahrain's Pharmaceutical Market Is Well Developed, But The Small Size Serves To Limit Its Attractiveness To Foreign Drug-makers. Mar 31, 2008 443 Research and Markets: The Pharmaceutical Market: Philippines Available Now for Review. Mar 19, 2008 367 The Pharmaceutical Market: Cuba - 2007 Update a Targeted Report Enabling You to Keep Up to Date With Market Developments for a Year. Mar 19, 2008 498 IMS Health Reports U.S. Prescription Sales Grew 3.8 Percent in 2007, to $286.5 Billion. Mar 12, 2008 997 Russia Pharmaceuticals & Healthcare Report Available Now. Report Mar 7, 2008 605 Gain an Analytical Insight Into the Major Factors Affecting the Bulgarian Logistics Market, Both Currently and in the Future. Mar 7, 2008 240 IT Budget Outlook, and Spending Priorities Among Pharmaceutical and Biotechnology Companies. Mar 3, 2008 266 Key Trends for the Global Cancer Market. Feb 19, 2008 2051 Cancer Market Outlook Report Compares the Future Prospects of Key Players and Forecast Sales of Leading Products Across Major Indications to 2012. Feb 15, 2008 762 Big pharma continues to make big changes. Feb 15, 2008 1209 Research and Markets: New Report a Detailed and Comprehensive Overview of Operations at Pharmaceutical Company, Ono. Feb 11, 2008 499 High Growth Forecasted for the Global Pain Pharmaceutical Market Analysis & Forecasts 2007-2022. Feb 8, 2008 2810 Learn about the Erectile Dysfunction Market Assessment & Analysis 2007-2022. Feb 7, 2008 1881 Hope on the horizon: Mel Frykberg reports from the occupied territories. Frykberg, Mel Feb 1, 2008 1371 Allergan Reports Fourth Quarter Operating Results. Jan 30, 2008 2923 Introducing Latest Study on 'Optimizing Partnerships with Contract Organizations: Effective Management, Key Issues and the Development of Virtual Pharmacos'. Jan 8, 2008 996 Amgen Updates 2007 Adjusted EPS Guidance and Outlines 2008 Expense Outlook at the JP Morgan Healthcare Conference. Conference news Jan 8, 2008 940 Celgene Corporation Reviews 2007 Achievements and Announces 2008 Financial Outlook. Jan 7, 2008 1028 Research and Markets: Benchmark Novartis' Performance against Key Rivals in the Ethical Pharmaceutical Sector. Jan 4, 2008 459 Zacks Analyst Interview Highlights: Medtronic, Boston Scientific, Johnson & Johnson and Abbott Labs. Jan 4, 2008 540 The FDA Raises Safety Concerns Regarding Off-Label Use of Avastin for Age-Related Macular Degeneration through Repackaging Avastin into Syringes for Intravitreal Delivery. Jan 2, 2008 762 Amgen layoffs had little economic impact locally: fewer pink slips given, future seems steady. Kareem, Nadra Dec 24, 2007 768 Merck's Vaccine Gardasil(TM) Will Be Best-Selling 2006-Approved Product, Forecasts URCH Report. Dec 14, 2007 391 Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction. Dec 10, 2007 1719 NRT Smoking Cessation Aids in China Report Offers a Comprehensive Guide to the Size and Shape of the Market at a National Level. Dec 7, 2007 1426 Research and Markets: Learn How Novo Nordisk's Dependency on Therapeutic Proteins and Focus on Market-Leading Administration Devices Insulates It from Biosimilar Competition. Dec 3, 2007 524 Research and Markets: In This New Report Evaluate Organons Prospects Out to 2012, Following the Recent $14.8 Billion Acquisition Bid by US-Based Big Pharma Schering-Plough. Dec 3, 2007 507 Focus on the Schering-Plough Corporation Company Profile. Nov 29, 2007 1632 Benchmark Novartis's Performance against Key Rivals. Nov 29, 2007 1503 The Global Antibacterials Market: R&D Pipelines, Market Analysis and Competitive Landscape. Nov 20, 2007 1551 Pharmaceuticals. Nov 15, 2007 179 Allergan Reports Third Quarter Operating Results. Financial report Nov 6, 2007 2993 URCH Publishing Announces Launch of Pharmaceutical Market Trends 2nd Edition Report. Nov 5, 2007 320 Meda AB (publ.) January - September 2007, Interim Report. Oct 30, 2007 3750 McKesson Expands Specialty Pharmaceutical Business with Agreement to Purchase OTN for $575 Million. Oct 4, 2007 1030 Get a Deep Insight into the Worldwide Veterinary Vaccines Market. Industry overview Sep 23, 2007 632 Zacks Bull and Bear of the Day Highlights: URS Corp., Pfizer, BASF and Alcatel-Lucent. Sep 21, 2007 1029 Launch Strategies - Analyzing Market Trends and Regulatory. Sep 4, 2007 360 The Outlook for Pharmaceuticals in Western Europe to 2012 - Forecast to Reach USD245.3 Billion. Aug 31, 2007 255 Competition Will Affect Future of Autoimmune Market. Aug 31, 2007 257 Waters. Aug 31, 2007 309 Find out Which Companies Are Best Positioned To Succeed In The Pharma Industry And What Will The Competitive Landscape Look Like Over The Period 2006-12. Aug 30, 2007 870 Growing demand prompts Pharmatek to boost drug development capabilities. Chambers, Heather Brief article Aug 27, 2007 169 Research and Markets: Pfizer Changes Its Pharmaceutical Distribution System in Europe. Aug 14, 2007 483 Zacks Bull and Bear of the Day Highlights: American Oriental Bioengineering, Centennial Communications, VeriSign and URS Corporation. Aug 13, 2007 962 Research and Markets: Genentech and Roche Continue to Command a Substantial Proportion of the Cancer Innovatives Market, Generating Almost 50% of All Sales in 2006. Aug 8, 2007 883 Report Provides Comprehensive Data and Analysis on the Russian Pharmaceutical Market. Report Aug 7, 2007 195 Research and Markets: Recordati Company Intelligence Reports Provide a Full Review of the Company's Activities Together with Five Year Sales Forecasts. Aug 3, 2007 665 Research and Markets: New Report Predicts that Novartis' Diovan, Glivec/Gleevec and Zelmac/Zelnorm will Continue to Show Healthy Sales Growth. Aug 3, 2007 705 Research and Markets: In Fiscal 2006, Mitsubishi Pharma Achieved Growth in Company Revenue for the First Time in Several Years, However, in Fiscal 2007, Net Sales Have Once Again Declined. Financial report Aug 3, 2007 657 Focus on the HIV / AIDS Market - Epidemiological Analysis, Leading Brands of Treatment, Market Trends and Key Pharmaceutical Companies. Aug 2, 2007 1439 Research and Markets: The New Strategic Analysis Report Johnson & Johnson: Performance, Products, Pipeline and Potential, Provides a Complete and Critical Review of the Company. Aug 2, 2007 601 Research and Markets: Chugai Pharmaceutical Company Report Provides A Full Review Of The Company's Activities Together With Five Year Sales Forecasts For Its Key Products. Aug 2, 2007 604 Research and Markets: A Comprehensive Review of the UCB Company's Products and Performance. Aug 2, 2007 522 Research and Markets: a Full Review of Gilead Sciences Company's Activities Together with Five-Year Sales Forecasts. Aug 2, 2007 504 Allergan Reports Second Quarter Operating Results. Financial report Aug 1, 2007 2440 Research and Markets: This New Strategic Analysis Report "Novo Nordisk: Performance, Products, Pipeline And Potential" Provides a Complete and Critical Review of the Company. Report Aug 1, 2007 673 Learn about the Top 20 Cancer Therapy Brands - Sales of Targeted Therapies Overtake Cytotoxics in 2006. Jul 24, 2007 1109 A Detailed Analysis of the Leading Players in the Indian Pharmaceutical Market. Jul 23, 2007 563 The Moroccan Pharmaceuticals Market is Explored and Analysed in Depth in New Report. Jul 20, 2007 196 Pharmaceutical & Biotech Lifecycle Management (I) - Are Generic's Launching Earlier Than Ever? Bucknell, Duncan Column Jul 19, 2007 746 The Countries of Western Europe Represent a Total Pharmaceuticals Market of over 365 Million People and a Combined GDP of US $14.4 Trillion in 2007. Jul 9, 2007 325 In Difficult Market Conditions, Pharmaceutical Companies Are Turning to the Biotech Industry for Innovation. Jul 2, 2007 394 Research and Markets: Teva is The Clear Market Leader since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs in the UK 2007. Jul 2, 2007 1059 EU. Jun 30, 2007 163 Denmark is a Global Leader in the Manufacture of Insulin and as a Consequence Has Retained a Healthy Balance of Payments Surplus for the Past Five Years States New Report on Denmark Pharmaceutical Market. Jun 21, 2007 413 Research and Markets: New Zealand Has Performed Well in the Pharmaceutical Markets and Also Professes to Have Negotiated Subsidy Reductions Worth Approximately NZ$50.7 Million During 2003/04. Jun 20, 2007 556 Betting on molecular diagnostics, QIAGEN buys Digene. Jun 15, 2007 375 Zacks Analyst Blog Highlights: Dollar Tree, AstraZeneca, MedImmune and FEMSA. Jun 6, 2007 907 Drug Expenditure in Turkey is Expected to Reach US$11.11bn by 2010. May 29, 2007 644 Research and Markets: Get A Full Review Of Alcon's Activities Together With Five-Year Sales Forecasts For Its Key Products. May 18, 2007 500 New Report Provides Detailed Data on the U.S. Generic Pharmaceuticals Market. May 16, 2007 407 Piribo: New Report on the Women's Health Pharmaceutical Market to 2011. May 9, 2007 385 The Legitimate Generics Sector's Share Of The Brazilian Market Reached 10.26% In The 12 Months To May 2006, With Annually Adjusted Growth Estimated At 31.3% In The Month - Brazil Pharmaceuticals & Healthcare Report Q4 2006. May 2, 2007 878 Akorn Reports Record Net Revenue of $71.2 Million in 2006: A 60% Increase Versus 2005. Financial report Mar 5, 2007 1194 Business briefs. Sep 18, 2004 440 Professional nurses' requests to remove their names from the South African Nursing Council's register Part 2: research process and results. Ehlers, Valerie J. Jun 1, 2003 6667